Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.24 USD
−54.42 M USD
0.00 USD
32.49 M
About Longboard Pharmaceuticals, Inc.
Sector
Industry
CEO
Kevin R. Lind
Website
Headquarters
La Jolla
Founded
2020
FIGI
BBG00Y0BJ9N5
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for neurological diseases. The company was founded on January 3, 2020 and is headquartered in San Diego, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of LBPH is 59.80 USD — it has increased by 0.05% in the past 24 hours. Watch Longboard Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Longboard Pharmaceuticals, Inc. stocks are traded under the ticker LBPH.
LBPH stock has risen by 0.07% compared to the previous week, the month change is a 0.83% rise, over the last year Longboard Pharmaceuticals, Inc. has showed a 1.33 K% increase.
We've gathered analysts' opinions on Longboard Pharmaceuticals, Inc. future price: according to them, LBPH price has a max estimate of 90.00 USD and a min estimate of 60.00 USD. Watch LBPH chart and read a more detailed Longboard Pharmaceuticals, Inc. stock forecast: see what analysts think of Longboard Pharmaceuticals, Inc. and suggest that you do with its stocks.
LBPH reached its all-time high on Nov 1, 2024 with the price of 59.95 USD, and its all-time low was 2.70 USD and was reached on Oct 27, 2022. View more price dynamics on LBPH chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LBPH stock is 0.10% volatile and has beta coefficient of −3.45. Track Longboard Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Longboard Pharmaceuticals, Inc. there?
Today Longboard Pharmaceuticals, Inc. has the market capitalization of 2.33 B, it has increased by 0.13% over the last week.
Yes, you can track Longboard Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Longboard Pharmaceuticals, Inc. is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
LBPH earnings for the last quarter are −0.63 USD per share, whereas the estimation was −0.58 USD resulting in a −8.89% surprise. The estimated earnings for the next quarter are −0.63 USD per share. See more details about Longboard Pharmaceuticals, Inc. earnings.
Longboard Pharmaceuticals, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
LBPH net income for the last quarter is −24.54 M USD, while the quarter before that showed −21.79 M USD of net income which accounts for −12.65% change. Track more Longboard Pharmaceuticals, Inc. financial stats to get the full picture.
No, LBPH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 50.00 employees. See our rating of the largest employees — is Longboard Pharmaceuticals, Inc. on this list?
Like other stocks, LBPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Longboard Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Longboard Pharmaceuticals, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Longboard Pharmaceuticals, Inc. stock shows the buy signal. See more of Longboard Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.